Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1999 Jan;80(1):77–79. doi: 10.1136/adc.80.1.77

Interferon α treatment of molluscum contagiosum in immunodeficiency

J Hourihane 1, E Hodges 1, J Smith 1, M Keefe 1, A Jones 1, G Connett 1
PMCID: PMC1717791  PMID: 10325766

Abstract

A sister (aged 6 years) and brother (aged 8 years) presented four months apart with severe molluscum contagiosum. Both children demonstrated clinical and laboratory evidence of combined immunodeficiency. The extent of skin involvement by molluscum contagiosum precluded conventional treatment as well as intralesional interferon α (IFNα). Both subjects responded well to subcutaneous IFNα.



Full Text

The Full Text of this article is available as a PDF (97.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbera C., Bortolotti F., Crivellaro C., Coscia A., Zancan L., Cadrobbi P., Nebbia G., Pillan M. N., Lepore L., Parrella T. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology. 1994 Aug;20(2):287–290. [PubMed] [Google Scholar]
  2. Benjamin B. N., Gatenby P. A., Kitchen R., Harrison H., Cameron K., Basten A. Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 1988 Jul-Aug;97(4 Pt 1):376–380. doi: 10.1177/000348948809700409. [DOI] [PubMed] [Google Scholar]
  3. Hicks C. B., Myers S. A., Giner J. Resolution of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir. Clin Infect Dis. 1997 May;24(5):1023–1025. doi: 10.1093/clinids/24.5.1023. [DOI] [PubMed] [Google Scholar]
  4. Kurwa H. A., Marks R. Protracted cutaneous disorders in association with low CD4+ lymphocyte counts. Br J Dermatol. 1995 Oct;133(4):625–629. doi: 10.1111/j.1365-2133.1995.tb02717.x. [DOI] [PubMed] [Google Scholar]
  5. Nelson M. R., Chard S., Barton S. E. Intralesional interferon for the treatment of recalcitrant molluscum contagiosum in HIV antibody positive individuals--a preliminary report. Int J STD AIDS. 1995 Sep-Oct;6(5):351–352. doi: 10.1177/095646249500600509. [DOI] [PubMed] [Google Scholar]
  6. Ruíz-Moreno M. Interferon treatment in children with chronic hepatitis B. J Hepatol. 1995;22(1 Suppl):49–51. [PubMed] [Google Scholar]
  7. Schwartz J. J., Myskowski P. L. Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol. 1992 Oct;27(4):583–588. doi: 10.1016/0190-9622(92)70226-6. [DOI] [PubMed] [Google Scholar]
  8. Vajro P., Tedesco M., Fontanella A., De Vincenzo A., Vecchione R., Ammendola R., Terracciano L. M., Novissimo A., Vegnente A. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. Pediatr Infect Dis J. 1996 Mar;15(3):223–231. doi: 10.1097/00006454-199603000-00010. [DOI] [PubMed] [Google Scholar]
  9. Wolf P., Müllegger R., Cerroni L., Aigner R., Fueger G., Höfler G., Derbaschnig J., Kerl H. Photoaccentuated erythroderma associated with CD4+ T lymphocytopenia: successful treatment with 5-methoxypsoralen and UVA, interferon alfa-2b, and extracorporeal photopheresis. J Am Acad Dermatol. 1996 Aug;35(2 Pt 2):291–294. doi: 10.1016/s0190-9622(96)90651-9. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES